Cevimeline hydrochloride hemihydrate
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. |
---|
Catalog Num | A15042 |
---|---|
Formula | C20H38Cl2N2O3S2 |
Molecular Weight | 489.6 |
CAS Number | 153504-70-2 |
SMILES | CC1O[C@]2(CN3CCC2CC3)CS1.CC1O[C@]2(CN3CCC2CC3)CS1.O.Cl.Cl |
Synonyms | Evoxac |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 35 mg/mL (142.98 mM) | |
Water | 35 mg/mL (142.98 mM) | ||
Ethanol | 35 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.42 mL | 102.12 mL | 204.25 mL |
0.5 mM | 4.08 mL | 20.42 mL | 40.85 mL |
1 mM | 2.04 mL | 10.21 mL | 20.42 mL |
5 mM | 0.41 mL | 2.04 mL | 4.08 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2